Search

Your search keyword '"Cancer genetics -- Forecasts and trends"' showing total 17 results
Start Over Descriptor "Cancer genetics -- Forecasts and trends"
17 results on '"Cancer genetics -- Forecasts and trends"'

1. 2019 Update of DiaCarta Inc, Product Pipeline Analysis - Serving Germany, Egypt, Iran, Turkey, Iraq & Costa Rica

Subjects
Colon cancer -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Gene mutation -- Forecasts and trends, Cancer diagnosis, Cancer, Biological markers, Diseases, DNA, Genes, Backup software, Colorectal cancer, Communicable diseases, Genetic testing, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: Research and Markets has issued the following news release: The 'DiaCarta Inc - Product Pipeline Analysis, 2019 Update' company profile has been added to ResearchAndMarkets.com's offering. Summary DiaCarta Inc [...]

Published
2020

2. 2019 Update of DiaCarta Inc, Product Pipeline Analysis - Serving Germany, Egypt, Iran, Turkey, Iraq & Costa Rica - ResearchAndMarkets.com

Subjects
Colon cancer -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Gene mutation -- Forecasts and trends, Cancer diagnosis, Cancer, Biological markers, Diseases, DNA, Genes, Backup software, Colorectal cancer, Communicable diseases, Genetic testing, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'DiaCarta Inc - Product Pipeline Analysis, 2019 Update' company profile has been added to ResearchAndMarkets.com's offering. Summary DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products [...]

Published
2020

3. 2019 Update of DiaCarta Inc, Product Pipeline Analysis - Serving Germany, Egypt, Iran, Turkey, Iraq & Costa Rica

Subjects
Colon cancer -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Gene mutation -- Forecasts and trends, Cancer diagnosis, Cancer, Biological markers, Diseases, DNA, Genes, Backup software, Colorectal cancer, Communicable diseases, Genetic testing, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-February 11, 2020-: 2019 Update of DiaCarta Inc, Product Pipeline Analysis - Serving Germany, Egypt, Iran, Turkey, Iraq & Costa Rica (C)1994-2020 M2 COMMUNICATIONS RDATE:11022020 The 'DiaCarta Inc - [...]

Published
2020

4. Cancer Genetics Named One of the Top 10 Drug Discovery & Development Solution Providers by Panel of Industry Experts at Pharma Tech Outlook

Subjects
Precision medicine -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Drug discovery -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

RUTHERFORD, N.J., Oct 31, 2017 (GLOBE NEWSWIRE via COMTEX) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ('CGI' or 'The Company'), a leader in enabling precision medicine for oncology through molecular markers and [...]

Published
2017

5. Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

Subjects
Medical tests -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Gene mutation -- Forecasts and trends, Colorectal cancer -- Forecasts and trends, Gastrointestinal diseases -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Denmark: Euroinvestor has issued the following news release: Biocartis Group NV ('Biocartis' or the 'Company'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the launch of the Idylla(TM) [...]

Published
2017

6. Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Others 2017-2020

Subjects
Cancer genetics -- Forecasts and trends, Tumors -- Forecasts and trends, DNA -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-April 3, 2017-: Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Others 2017-2020 (C)1994-2017 M2 COMMUNICATIONS RDATE:03042017 Dublin - Research and [...]

Published
2017

7. Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Others 2017-2020

Subjects
Cancer genetics -- Forecasts and trends, Blood tests -- Forecasts and trends, Tumors -- Forecasts and trends, DNA -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Apr 03, 2017 (M2 PRESSWIRE via COMTEX) -- Research and Markets has announced the addition of the 'Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, [...]

Published
2017

8. The future of cancer genomics: with the completion of the cancer genome atlas, it is time to evaluate its impact and mine its data to gain a better understanding of cancer biology and therapy

Subjects
Data mining -- Methods, Cancer treatment -- Genetic aspects, Cancer genetics -- Forecasts and trends, Data warehousing/data mining, Market trend/market analysis, Biological sciences, Health
Abstract

The Cancer Genome Atlas (TCGA) will wind down in 2015, bringing to a close one of the most ambitious large-scale initiatives spearheaded by the US National Institutes of Health. Starting [...]

Published
2015

9. Veracyte Announces New Data that Advance Understanding of the Role of Gene Alterations In Thyroid Cancer Diagnosis

Subjects
Thyroid cancer -- Forecasts and trends, Cancer diagnosis -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Genes -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

-- Findings presented at the American Association of Clinical Endocrinologists (AACE) Meeting -- SOUTH SAN FRANCISCO, Calif., May 27, 2016 /PRNewswire/ -- http://www.veracyte.com/ (NASDAQ: VCYT), a molecular diagnostics company pioneering [...]

Published
2016

10. Veracyte Announces Publication of Data Supporting Clinical Utility of the Percepta Bronchial Genomic Classifier in Lung Cancer Diagnosis

Subjects
Lung cancer -- Forecasts and trends, Cancer diagnosis -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2016 /PRNewswire/ -- http://www.veracyte.com/ . (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that data supporting the ability of [...]

Published
2016

11. Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma Gene Expression Classifier in Thyroid Cancer Diagnosis

Subjects
Thyroid cancer -- Forecasts and trends, Cancer diagnosis -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Cancer research -- Forecasts and trends, Gene expression -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO, Calif., Feb. 19, 2016 /PRNewswire/ -- http://www.veracyte.com/ (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, announced that an independent clinical utility study reinforcing [...]

Published
2016

12. Veracyte Presents New Data on Gene Variants and Fusions In Thyroid Cancer Diagnosis

Subjects
Thyroid cancer -- Forecasts and trends, Cancer diagnosis -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Genes -- Forecasts and trends, RNA sequencing -- Forecasts and trends, Genomics -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2015 /PRNewswire/ -- http://www.veracyte.com/ (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced findings from a new study of [...]

Published
2015

13. New American Thyroid Association Guidelines Include Recommendation for Veracyte's Afirma Gene Expression Classifier to Rule Out Cancer in Indeterminate Thyroid Nodules

Subjects
Cancer genetics -- Forecasts and trends, Thyroid diseases -- Forecasts and trends, Gene expression -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2015 /PRNewswire/ -- http://www.veracyte.com/ (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that new guidelines from the American [...]

Published
2015

14. Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Subjects
Hormones -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Cancer -- Forecasts and trends, Biological markers -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 23, 2015-: Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (C)1994-2015 M2 COMMUNICATIONS RDATE:23062015 Dublin - Research and Markets [...]

Published
2015

15. Analysis of the European Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

Subjects
Hospitals -- Forecasts and trends, Hormones -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Cancer -- Forecasts and trends, Biological markers -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 23, 2015-: Analysis of the European Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations (C)1994-2015 M2 COMMUNICATIONS RDATE:23062015 Dublin [...]

Published
2015

16. Analysis of the German Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Subjects
Hormones -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Cancer -- Forecasts and trends, Medical offices -- Forecasts and trends, Biological markers -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 23, 2015-: Analysis of the German Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (C)1994-2015 M2 COMMUNICATIONS RDATE:23062015 Dublin - Research and Markets [...]

Published
2015

17. Analysis of the European Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

Subjects
Hospitals -- Forecasts and trends, Hormones -- Forecasts and trends, Cancer genetics -- Forecasts and trends, Cancer -- Forecasts and trends, Biological markers -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Jun 23, 2015 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/gcm22j/2015_market) has announced the addition of the '2015 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results